BAA pmwp#81: "assessment of the efficacy of acute pain treatments: an RTC RE-analysis"

Ended Definitive Contract Awarded Last action

Contract number
75F40119C10099
Awardee
Awarding agency
Obligated
$3,114,119

Award facts

Opportunity
  • FDABAA1900123 Solicitation number
Contract value 70% obligated
  • $3,114,119.21 Current, with exercised options
  • $4,424,934.21 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 11 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Philadelphia, PA 19104, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00007 $0
Other Administrative Action P00006 $0
Other Administrative Action P00005 · Assessment of the efficacy of acute pain treatments an RTC RE-analysis $4
Other Administrative Action P00004 · Update invoicing and payment requirements. Make action eligible for submission of invoices through the invoice processing platform (IPP). $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Exercise an Option P00001 $514,115
Original award $2,600,000

About this award

The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, has been awarded a definitive cost-no-fee contract valued at $4,424,934.21 by the Department of Health and Human Services Food and Drug Administration to conduct the project "Assessment of the Efficacy of Acute Pain Treatments: An RTC Re-Analysis" in Philadelphia, Pennsylvania. Under this contract, the University of Pennsylvania will analyze previously collected data to re-evaluate acute pain treatments, providing the FDA insights to help improve the assessment of new and existing pain therapies. The base period of performance is from September 2019 through September 2024. No subcontractors or set-aside designations were identified.

Quick answers

Who was awarded contract 75F40119C10099?

75F40119C10099 was awarded to The Trustees Of The University Of Pennsylvania by Food and Drug Administration (Department of Health and Human Services) on September 12, 2019.

How much is contract 75F40119C10099 worth?

The government has obligated $3,114,119 on 75F40119C10099. Its potential value, with all options, is $4,424,934.

Was contract 75F40119C10099 competed?

The extent of competition for 75F40119C10099 was full and open competition. The government received 11 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award